Support for patients
This site is designed to provide information to patients who have been prescribed an Amgen® medicine. If you are a member of the public and have not been prescribed any of these Amgen medicines please find below a link to the Amgen website. Should you have any concerns or questions regarding your treatment, please speak to your doctor or nurse.
Please select one of the options below:
I am, or I care for, an AMGEVITA®▼ (adalimumab) patient.
I am, or I care for, a Repatha® (evolocumab) patient.
I am, or I care for, a Neulasta® ONPRO® (pegfilgrastim) patient.
I am, or I care for, a Nplate® (romiplostim) patient.
I am, or I care for, a XGEVA® (denosumab) patient.
I am, or I care for, an OTEZLA® (apremilast) patient.
I am a member of the general public and have not been prescribed any of these Amgen® medicines.
▼ This medicinal product is subject to additional monitoring.
Reporting of side effects:
If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet. By reporting side effects you can help provide more information on the
safety of this medicine.
You can also report side effects directly via the Yellow Card Scheme at https://yellowcard.mhra.gov.uk.
Side effects should also be reported to Amgen Limited on +44 (0) 1223 436441.
Please report any potential quality issue with the Amgen product you have received, by calling us on +44 (0) 1223 436441 and providing us with the details. Please ensure that you keep your packaging, so we are able to identify your product more easily.